Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by fredgoodwinsonon Jun 10, 2020 8:06am

158 Views

Post# 31132174

RE:RE:RE:Does Health Canada

My puzzle is as to why the start of the small Phase IB with Rutherrin that they now claim to be lined up for in Canada should in any way be delayed by an alleged requirement for them to have first launched 20 sites - mostly in the States - for NMIBC?

Fail to see any connection between the two.

Bullboard Posts

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta